Exploiting nanopore sequencing for characterization and grading of IDH ‐mutant gliomas
Brain Pathology · 2024
DOI: 10.1111/bpa.13203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, 2024. Verfasst von Thidathip Wongsurawat und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Bioinformatics, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thaila…. Hauptthemen laut MEDLINE: Oligodendroglioma, Brain Neoplasms, Nanopore Sequencing, Glioma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation, Thailand.
Abstract (Originalsprache)
The 2021 WHO Classification of Central Nervous System Tumors recommended evaluation of cyclin‐dependent kinase inhibitor 2A/B ( CDKN2A/B ) deletion in addition to codeletion of 1p/19q to characterize IDH‐ mutant gliomas. Here, we demonstrated the use of a nanopore‐based copy‐number variation sequencing (nCNV‐seq) approach to simultaneously identify deletions of CDKN2A/B and 1p/19q. The nCNV‐seq approach was initially evaluated on three distinct glioma cell lines and then applied to 19 IDH ‐mutant gliomas (8 astrocytomas and 11 oligodendrogliomas) from patients. The whole‐arm 1p/19q codeletion was detected in all oligodendrogliomas with high concordance among nCNV‐seq, FISH, DNA methylation profiling, and whole‐genome sequencing. For the CDKN2A/B deletion, nCNV‐seq detected the loss in both astrocytoma and oligodendroglioma, with strong correlation with the CNV profiles derived from whole‐genome sequencing (Pearson correlation ( r ) = 0.95, P < 2.2 × 10 −16 to r = 0.99, P < 2.2 × 10 −16 ) and methylome profiling. Furthermore, nCNV‐seq can differentiate between homozygous and hemizygous deletions of CDKN2A/B . Taken together, nCNV‐seq holds promise as a new, alternative approach for a rapid and simultaneous detection of the molecular signatures of IDH ‐mutant gliomas without capital expenditure for a sequencer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Bioinformatics, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Department of Biomedical Informatics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
- Department of Medicine (Neurology), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
- Department of Environmental and Occupational Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
- Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
ORCID-Profile: Gunnar Boysen, Jantima Tanboon, Sith Sathornsumetee
Förderung
- NIGMS NIH HHS
- Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation, Thailand
Zitieren
APA
Wongsurawat, T., Jenjaroenpun, P., Anekwiang, P., Arigul, T., Thongrattana, W., Jamshidi-Parsian, A., Boysen, G., Suriyaphol, P., Suktitipat, B., Srirabheebhat, P., Cheunsuchon, P., Tanboon, J., Nookaew, I., & Sathornsumetee, S. (2024). Exploiting nanopore sequencing for characterization and grading of IDH ‐mutant gliomas. Brain Pathology. https://doi.org/10.1111/bpa.13203
Vancouver
Wongsurawat T, Jenjaroenpun P, Anekwiang P, Arigul T, Thongrattana W, Jamshidi-Parsian A, et al. Exploiting nanopore sequencing for characterization and grading of IDH ‐mutant gliomas. Brain Pathology. 2024. doi:10.1111/bpa.13203
BibTeX
@article{Wongsurawat2024,
author = {Wongsurawat, Thidathip and Jenjaroenpun, Piroon and Anekwiang, Panatna and Arigul, Tantip and Thongrattana, Wichayapat and Jamshidi-Parsian, Azemat and Boysen, Gunnar and Suriyaphol, Prapat and Suktitipat, Bhoom and Srirabheebhat, Prajak and Cheunsuchon, Pornsuk and Tanboon, Jantima and Nookaew, Intawat and Sathornsumetee, Sith},
title = {Exploiting nanopore sequencing for characterization and grading of IDH ‐mutant gliomas},
journal = {Brain Pathology},
year = {2024},
doi = {10.1111/bpa.13203}
}
EUVIMED